Linda Coleman joined Yale University as its Director of Human Research Protection Program in April 2016. Prior to joining Yale, she held several positions at Quorum Review, an independent IRB that provides ethics review and consulting services to institutional, independent, and international sites. From January – April 2016, Ms. Coleman served as Quorum’s Vice President of Regulatory & Legal Affairs. Prior to 2016, she served as Quorum’s Director of Regulatory Affairs & General Counsel from 2011 – 2015, and its Director of Regulatory Affairs from 2007 – 2010.
Since 2011, Ms. Coleman has been a Task Force Member of the Industry Pharmacogenomics Education Task Force, a subcommittee of the Industry Pharmacogenomics Working Group (I-PWG). Ms. Coleman is also the Team Lead for the Mobile Clinical Trials working group of the Clinical Trials Transformation Initiative, and actively participates on other committees related to research.
Prior to joining Quorum, Ms. Coleman was an attorney at Bennett, Bigelow & Leedom in Seattle, Washington where her practice focused on regulatory compliance, Medicare and Medicaid reimbursement, health care litigation, business/transactional, behavioral health, employment law, and general patient care delivery matters.